Explore UAB

Colleges & Schools

Center for Addiction and Pain Prevention and Intervention
  • CAPPI Member Research Spotlight: Karen Cropsey, PsyD
  • UAB among first in US to offer new spinal cord stimulator therapy for chronic pain
  • CBS News: CDC's new opioid guidelines are too little, too late for chronic pain patients, experts say
  • CAPPI Member Research Spotlight: Peter Hendricks, Ph.D.
  • CAPPI Member Research Spotlight: Peter Hendricks, Ph.D.

  • Cropsey and Gamble recipients of New NIH grant

    CAPPI Member Research Spotlight: Karen Cropsey, PsyD

    This study investigates why individuals with opioid use disorder, who are maintained on opioids for treatment, often suffer from poor sleep. While the connection between opioid use and sleep problems is well-known, the underlying biological mechanisms remain unclear.

    Read more →

  • UAB among first in US to offer new spinal cord stimulator therapy for chronic pain

    CAPPI Member Research Spotlight: Christopher Paul, Ph.D.

    For patients with chronic pain that has not been resolved by conservative treatments, physicians at the University of Alabama at Birmingham Pain Treatment Clinic at UAB Hospital-Highlands are offering a new treatment option designed to provide long-term relief.

    Read more →

  • CBS News: CDC's new opioid guidelines are too little, too late for chronic pain patients, experts say

    CAPPI Member Research Spotlight: Stefan Kertesz, M.D.

    Many have struggled to get opioid prescriptions written and filled since 2016 guidelines from the Centers for Disease Control and Prevention inspired laws cracking down on doctor and pharmacy practices. The CDC recently updated those recommendations to try to ease their impact, but doctors, patients, researchers, and advocates say the damage is done.

    Read more →

  • UAB and Diamond Therapeutics, Inc. launch psilocybin clinical trial

    CAPPI Member Research Spotlight: Peter Hendricks, Ph.D.

    Researchers at the University of Alabama at Birmingham, Johns Hopkins University and New York University were awarded nearly $4 million in funding to study the efficacy of psilocybin, a classic psychedelic compound, in helping people quit smoking. The grant from the National Institute on Drug Abuse is the first federally funded study of a classic psychedelic as a therapeutic in approximately 50 years.

    Read more →

  • Magic mushrooms: UAB studying benefits for addiction and pain

    CAPPI Member Research Spotlight: Peter Hendricks, Ph.D.

    Psychedelic drugs creating hopes for breakthroughs in depression, anxiety, pain and addiction are being tested at UAB. The university is one of a handful in the nation conducting trials with psilocybin, the active ingredient in hallucinogenic mushrooms.

    Read more →
CAPPI logo

CAPPI: Improving addiction and pain outcomes through research, education, community outreach, and patient care resources

The mission of CAPPI is to conduct cutting-edge research that can be developed into better treatments for addiction and pain. The faculty and staff in CAPPI seek to educate other professionals and the public about addiction and pain in a way that promotes compassion and minimizes the stigma of these two health conditions. CAPPI also serves as the focal point for community outreach in order to build effective partnerships with the communities we serve.

CAPPI supports the community in local outreach programs


Community Events

Upcoming Events

 

More Events

Back to Top